Table 1.
Association of NPTX1 expression with the GC clinicopathological characteristics in TCGA cohort
| N (351) | NPTX1 expression level
|
P-value | ||
|---|---|---|---|---|
| Low [n (%)] | High [n (%)] | |||
| Gender | 0.373 | |||
| Female | 125 | 58 (46.4) | 67 (53.6) | |
| Male | 226 | 117 (51.8) | 109 (48.2) | |
| Age (years) | 0.031 | |||
| ≤60 | 116 | 48 (41.4) | 68 (58.6) | |
| >60 | 235 | 127 (54.0) | 108 (46.0) | |
| Tumor stage | 0.07 | |||
| T1–T3 | 257 | 136 (52.9) | 121 (47.1) | |
| T4 | 94 | 39 (41.5) | 55 (58.5) | |
| Lymph node stage | 0.015 | |||
| N0 | 107 | 64 (59.8) | 43 (40.2) | |
| N1–N3 | 244 | 111 (47.6) | 133 (57.1) | |
| Metastasis stage | 0.542 | |||
| M0 | 326 | 161 (49.4) | 165 (50.6) | |
| M1 | 25 | 14 (56) | 11 (44) | |
Note: Bold values indicate statistical significance, P<0.05.
Abbreviations: GC, gastric cancer; TCGA, The Cancer Genome Atlas.